Global Ureteral Stents Market Size By Type (Double Pigtail Stents, Closed End Stents), By Application (Hospital, Clinical), By Region, And Segment Forecasts, 2023 to 2032

The Global Ureteral Stents Market was valued at USD 650 million in 2023 and is projected to surpass USD 1.1 billion by 2031, growing at a CAGR of 6.8% during the forecast period of 2023-2031. The increasing prevalence of kidney stones, urinary tract infections (UTIs), and ureteral obstructions, along with the rising adoption of minimally invasive urological procedures, are the key drivers of market growth.

Advancements in biodegradable stents, drug-eluting stents, and smart stents have further expanded the market, improving patient outcomes and reducing complications. The aging population, increasing awareness regarding kidney health, and improved healthcare infrastructure in emerging markets are also fueling market expansion.

Market Drivers

1. Rising Prevalence of Kidney Stones and Urological Disorders

The increasing incidence of kidney stones, ureteral strictures, and urological malignancies has driven the demand for ureteral stents. Lifestyle changes, dietary habits, and chronic diseases like obesity and diabetes have further contributed to the rising urological disease burden.

2. Growth in Minimally Invasive Procedures

Minimally invasive techniques such as ureteroscopy and percutaneous nephrolithotomy (PCNL) are gaining popularity due to their reduced recovery time and lower risk of complications. The demand for innovative and patient-friendly ureteral stents is rising in response.

3. Technological Advancements in Ureteral Stents

Advancements in biodegradable stents, anti-encrustation coatings, and drug-eluting stents are addressing infection risks and stent-related discomfort, improving overall patient experiences and expanding market opportunities.

4. Aging Population and Increasing Healthcare Expenditure

An aging global population is more susceptible to kidney diseases and urinary complications, boosting the demand for ureteral stents. Additionally, increasing healthcare investments in emerging economies are making advanced treatments more accessible.

Market Restraints

1. Risk of Stent-Related Complications

Despite technological advancements, stent-related infections, migration, encrustation, and discomfort continue to be major concerns. This has led to frequent stent removals and replacements, affecting overall patient compliance.

2. High Cost of Advanced Ureteral Stents

Although traditional ureteral stents are affordable, next-generation stents with drug-eluting properties or biodegradable materials can be expensive, limiting their adoption in price-sensitive markets.

3. Lack of Skilled Healthcare Professionals

The placement and removal of ureteral stents require specialized skills. A shortage of trained urologists and medical professionals in developing regions can hinder market penetration.

Market Opportunities

1. Development of Smart and Drug-Eluting Ureteral Stents

The integration of biodegradable, drug-eluting, and sensor-equipped stents to monitor urine flow and detect infections offers huge growth potential for market players.

2. Expansion in Emerging Markets

With improving healthcare infrastructure and growing patient awareness in Asia-Pacific, Latin America, and the Middle East, companies are investing in low-cost yet advanced stents to tap into these high-growth regions.

3. Rising Adoption of Disposable and Biodegradable Stents

The shift towards single-use, biodegradable stents is gaining traction due to their lower infection risks and reduced need for removal surgeries.

Market Segmentation Insights

Market by Product Type

Double J Stents (Dominating Segment in 2023)

Metal Ureteral Stents

Biodegradable Ureteral Stents

Drug-Eluting Ureteral Stents

Among these, double J stents held the largest market share in 2023 due to their widespread usage, affordability, and effectiveness. However, biodegradable and drug-eluting stents are anticipated to witness the fastest growth.

Market by Material Type

Polymer-based Stents (Silicone & Polyurethane)

Metallic Stents

Polymer-based stents are the most widely used due to their flexibility and cost-effectiveness, while metallic stents are preferred in chronic cases for their long-term durability.

Market by End-Use

Hospitals (Largest Segment, Over 50% Share in 2023)

Ambulatory Surgical Centers (ASCs)

Specialty Clinics

Hospitals dominate due to high patient admissions for kidney stones and urological procedures, but ambulatory surgical centers (ASCs) are growing rapidly due to the preference for outpatient procedures.

Market by Region

North America (Largest Market in 2023, Driven by High Healthcare Spending)

Europe (Second Largest, Due to Advanced Urological Care Facilities)

Asia-Pacific (Fastest Growing, Due to Increasing Urological Cases and Expanding Healthcare Access)

Latin America and Middle East & Africa (Steady Growth)

North America dominates, contributing over 40% of the total market share in 2023 due to strong healthcare infrastructure, high awareness, and robust reimbursement policies. Meanwhile, Asia-Pacific is expected to register the highest CAGR, driven by rising urological disease prevalence and improving medical access.

Competitive Scenario

Key players in the global ureteral stents market include:

Boston Scientific Corporation

Becton, Dickinson and Company (BD)

Cook Medical

Teleflex Incorporated

B. Braun Melsungen AG

Coloplast Corp.

Olympus Corporation

Allium Medical Solutions Ltd.

C.R. Bard, Inc.

Medline Industries, LP

These companies are focusing on technological innovations, mergers & acquisitions, and geographical expansions to strengthen their market presence.

Key Market Developments

In 2023, Boston Scientific introduced a biodegradable ureteral stent, reducing the need for secondary removal surgeries.

Olympus Corporation launched a new drug-eluting ureteral stent, designed to prevent infections and encrustations.

Cook Medical expanded its production facilities in 2024, catering to the growing demand for minimally invasive ureteral stents.

Scope of Work – Global Ureteral Stents Market